Literature DB >> 11556490

Control and impairment of immune privilege in the testis and in semen.

A Filippini1, A Riccioli, F Padula, P Lauretti, A D'Alessio, P De Cesaris, L Gandini, A Lenzi, E Ziparo.   

Abstract

It has long been known that the testis is an immunologically privileged site in the body, and that human seminal plasma possesses a generalized immunosuppressive activity. Multiple factors participate in the establishment of immunotolerance in the testis: the blood-tubular barrier; the local production of immunosuppressive molecules by Sertoli cells; and the Fas system as regulator of immunological homeostasis in both physiological and pathological conditions. Cytokine-induced up-regulation of Fas as well as of integrin ligands, which are known to be specific binding molecules for lymphocytes on the Sertoli cell surface, indicates that the 'nursing' cells of seminiferous epithelium might be important in the impairment of immune privilege, causing autoimmune orchitis. In addition, the soluble form of Fas-ligand protein present in the seminal plasma of infertile patients might suggest a role for this immunomodulatory protein in male infertility. Finally, an understanding of the mechanisms underlying immune privilege in the testis and in semen might help to clarify how cells expressing 'non-self' antigens (such as male gametes) can escape the immune system in both the male and female genital tracts.

Entities:  

Mesh:

Year:  2001        PMID: 11556490     DOI: 10.1093/humupd/7.5.444

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  21 in total

1.  Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.

Authors:  Taisuke Ito; Natsuho Ito; Albrecht Bettermann; Yoshiki Tokura; Masahiro Takigawa; Ralf Paus
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

2.  Intraocular lymphoma following a primary testicular lymphoma in remission for 10 years.

Authors:  K Aliferis; C C Chan; G Donati; E Baglivo
Journal:  Int Ophthalmol       Date:  2007-11-06       Impact factor: 2.031

3.  Primary testicular and intraocular lymphomas: two case reports and a review of the literature.

Authors:  Dana J Wallace; Chandra R Altemare; De Fen Shen; Marc D deSmet; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 6.048

4.  Diagnosis of systemic metastatic retinal lymphoma.

Authors:  Xiaoguang Cao; Defen Shen; David G Callanan; Manabu Mochizuki; Chi-Chao Chan
Journal:  Acta Ophthalmol       Date:  2011-03       Impact factor: 3.761

5.  Characterization and functionality of proliferative human Sertoli cells.

Authors:  Kitty Chui; Alpa Trivedi; C Yan Cheng; Diana B Cherbavaz; Paul F Dazin; Ai Lam Thu Huynh; James B Mitchell; Gabriel A Rabinovich; Linda J Noble-Haeusslein; Constance M John
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

Review 6.  Alzheimer's disease, brain immune privilege and memory: a hypothesis.

Authors:  Y I Arshavsky
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

Review 7.  Cutting-edge issues in autoimmune orchitis.

Authors:  Clovis A Silva; Marcello Cocuzza; Eduardo F Borba; Eloísa Bonfá
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

8.  Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.

Authors:  Peter J Dupont; Anthony N Warrens
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

Review 9.  Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines.

Authors:  Maurizio Chiriva-Internati; Everardo Cobos; Diane M Da Silva; W Martin Kast
Journal:  Cancer Immun       Date:  2008-04-24

Review 10.  Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.

Authors:  Philip V Nguyen; Jessica K Kafka; Victor H Ferreira; Kristy Roth; Charu Kaushic
Journal:  Cell Mol Immunol       Date:  2014-06-30       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.